• Publications
  • Influence
ESC Guidelines on the Diagnosis and Treatment of Peripheral Artery Diseases
Endorsed by: the European Stroke Organisation (ESO) Authors/Task Force Members: Michal Tendera (Chairperson) (Poland), Victor Aboyans (Co-Chairperson) (France), Marie-Louise Bartelink (TheExpand
  • 1,371
  • 65
  • PDF
Renal artery stenosis
  • T. Zeller
  • Medicine
  • Current treatment options in cardiovascular…
  • 18 May 2007
Opinion statementFibromuscular dysplasia (FMD) and aortoarteritis are the most frequent causes of secondary hypertension induced by renal artery stenosis (RAS). Revascularization of this diseaseExpand
  • 269
  • 22
  • PDF
Medial vascular calcification revisited: review and perspectives.
Vascular calcifications (VCs) are actively regulated biological processes associated with crystallization of hydroxyapatite in the extracellular matrix and in cells of the media (VCm) or intima (VCi)Expand
  • 343
  • 17
Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.
BACKGROUND Drug-eluting stents reduce restenosis in coronary arteries, but clinical trials have failed to prove their efficacy in peripheral arteries. We investigated the use of paclitaxel-coatedExpand
  • 606
  • 16
Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease: Twelve-Month Zilver PTX Randomized Study Results
Background— Sustained benefits of drug-eluting stents in femoropopliteal arteries have not been demonstrated. This prospective, multinational, randomized study was designed to compare the 12-monthExpand
  • 463
  • 14
Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease.
OBJECTIVE Critical limb ischemia, the most severe form of peripheral arterial disease, results in extremity amputation if left untreated. Endovascular recanalization of stenotic or occludedExpand
  • 193
  • 14
Drug-Eluting and Bare Nitinol Stents for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery: Long-Term Results from the SIROCCO Trial
Purpose: To review clinical outcomes of patients with chronic limb ischemia and TASC type C lesions treated with sirolimus-eluting versus bare SMART nitinol self-expanding stents. Methods: Data wereExpand
  • 435
  • 13
The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated
OBJECTIVES This study sought to evaluate the safety and efficacy of the Lutonix drug-coated balloon (DCB) coated with 2 μg/mm(2)paclitaxel and a polysorbate/sorbitol carrier for treatment ofExpand
  • 287
  • 9
Long-term results after directional atherectomy of femoro-popliteal lesions.
OBJECTIVES Our objective in this research was the evaluation of the long-term results after directional atherectomy using the Silverhawk device (FoxHollow Technologies, Redwood City, California) ofExpand
  • 196
  • 9
  • PDF
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation.
Hypertension is highly prevalent and one of the most frequent chronic diseases worldwide.1 It has been suggested that over the next two decades up to 50% of the adult population will be diagnosedExpand
  • 239
  • 9
  • PDF